Company News

Filter by:

August 2014

FDB Adds Boxed Warning Content to Help Ensure Patient Safety with High Risk Medications

August 07, 2014

Posted August 7, 2014 - FDB adds boxed warning content to the FDB High Risk Medication Module to ensure patient safety and regulatory compliance with high risk medications within the clinical workflow. Continue Reading

June 2014

Innovative Integrated Medicine’s Management Solution being presented at the June 2014 Commissioning Show

June 23, 2014

Posted 23 June 2014 - Lincolnshire East Clinical Commissioning Group (LECCG) will be presenting their experiences of the OptimiseRx electronic medicines management clinical decision support pilot which concluded in early 2014. Continue Reading

May 2014

FDB to Present Poster on the Quality and Consistency of Grapefruit Juice Drug Interaction Information at Patient Safety Conference

May 14, 2014

Posted May 13, 2014 - FDB research on the quality and consistency of grapefruit juice drug interaction information, presented at NPSF Conference, reveals numerous inconsistencies in manufacturer-authored drug labeling. Continue Reading

April 2014

FDB to Present Expert Panel Drug Dosing Recommendations at 2014 Pediatric Pharmacy Conference

April 30, 2014

Posted April 30, 2014 - FDB to Present Expert Panel Pediatric Drug Dosing Recommendations at 2014 Pediatric Pharmacy Conference Continue Reading

March 2014

FDB to Present Drug Pricing Analysis Poster Comparing AWP and WAC to AAC Benchmarks

March 31, 2014

Posted March 31, 2014 - FDB Drug Pricing Analysis Poster Comparing AWP and WAC to AAC Benchmarks finds acquisition cost-based benchmarks a more reliable measure for drug cost effectiveness studies. Continue Reading

FDB MedsTracker® Achieves 2014 Edition Modular EHR Health IT Certification from ICSA Labs

March 20, 2014

March 20, 2014 - FDB MedsTracker® achieves 2014 Edition Modular EHR Health IT Certification from ICSA Labs for both inpatient and ambulatory settings. This certification designates that FDB MedsTracker is capable of supporting healthcare providers with Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA). Continue Reading